• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外囊泡及其在骨关节炎发病机制和治疗中的潜在意义

Extracellular Vesicles and Their Potential Significance in the Pathogenesis and Treatment of Osteoarthritis.

作者信息

Mustonen Anne-Mari, Nieminen Petteri

机构信息

Institute of Biomedicine, School of Medicine, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland.

Department of Environmental and Biological Sciences, Faculty of Science and Forestry, University of Eastern Finland, P.O. Box 111, FI-80101 Joensuu, Finland.

出版信息

Pharmaceuticals (Basel). 2021 Apr 1;14(4):315. doi: 10.3390/ph14040315.

DOI:10.3390/ph14040315
PMID:33915903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8065796/
Abstract

Osteoarthritis (OA) is a chronic joint disease characterized by inflammation, gradual destruction of articular cartilage, joint pain, and functional limitations that eventually lead to disability. Join tissues, including synovium and articular cartilage, release extracellular vesicles (EVs) that have been proposed to sustain joint homeostasis as well as to contribute to OA pathogenesis. EVs transport biologically active molecules, and OA can be characterized by altered EV counts and composition in synovial fluid. Of EV cargo, specific non-coding RNAs could have future potential as diagnostic biomarkers for early OA. EVs may contribute to the propagation of inflammation and cartilage destruction by transporting and enhancing the production of inflammatory mediators and cartilage-degrading proteinases. In addition to inducing OA-related gene expression patterns in synoviocytes and articular chondrocytes, EVs can induce anti-OA effects, including increased extracellular matrix deposition and cartilage protection. Especially mesenchymal stem cell-derived EVs can alleviate intra-articular inflammation and relieve OA pain. In addition, surgically- or chemically-induced cartilage defects have been repaired with EV therapies in animal models. While human clinical trials are still in the future, the potential of actual cures to OA by EV products is very promising.

摘要

骨关节炎(OA)是一种慢性关节疾病,其特征为炎症、关节软骨逐渐破坏、关节疼痛以及最终导致残疾的功能受限。包括滑膜和关节软骨在内的关节组织会释放细胞外囊泡(EVs),这些囊泡被认为有助于维持关节稳态以及参与骨关节炎的发病机制。细胞外囊泡运输生物活性分子,骨关节炎的特征可能是滑液中细胞外囊泡数量和组成的改变。在细胞外囊泡的货物中,特定的非编码RNA未来可能具有作为早期骨关节炎诊断生物标志物的潜力。细胞外囊泡可能通过运输和增强炎症介质及软骨降解蛋白酶的产生,促进炎症传播和软骨破坏。除了在滑膜细胞和关节软骨细胞中诱导骨关节炎相关的基因表达模式外,细胞外囊泡还可诱导抗骨关节炎作用,包括增加细胞外基质沉积和保护软骨。特别是间充质干细胞衍生的细胞外囊泡可以减轻关节内炎症并缓解骨关节炎疼痛。此外,在动物模型中,已通过细胞外囊泡疗法修复了手术或化学诱导的软骨缺损。虽然人类临床试验尚在未来,但细胞外囊泡产品实际治愈骨关节炎的潜力非常可观。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7639/8065796/d4d7f5ee955b/pharmaceuticals-14-00315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7639/8065796/59b0a9bd7979/pharmaceuticals-14-00315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7639/8065796/d4d7f5ee955b/pharmaceuticals-14-00315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7639/8065796/59b0a9bd7979/pharmaceuticals-14-00315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7639/8065796/d4d7f5ee955b/pharmaceuticals-14-00315-g002.jpg

相似文献

1
Extracellular Vesicles and Their Potential Significance in the Pathogenesis and Treatment of Osteoarthritis.细胞外囊泡及其在骨关节炎发病机制和治疗中的潜在意义
Pharmaceuticals (Basel). 2021 Apr 1;14(4):315. doi: 10.3390/ph14040315.
2
Harnessing Tissue-derived Extracellular Vesicles for Osteoarthritis Theranostics.利用组织衍生的细胞外囊泡进行骨关节炎治疗学研究。
Theranostics. 2022 Jan 1;12(1):207-231. doi: 10.7150/thno.62708. eCollection 2022.
3
Intra-articular delivery of extracellular vesicles secreted by chondrogenic progenitor cells from MRL/MpJ superhealer mice enhances articular cartilage repair in a mouse injury model.关节内注射软骨祖细胞来源的细胞外囊泡可增强 MRL/MpJ 超级愈合小鼠模型中关节软骨的修复。
Stem Cell Res Ther. 2020 Mar 2;11(1):93. doi: 10.1186/s13287-020-01594-x.
4
Cartilage progenitor cells derived extracellular vesicles-based cell-free strategy for osteoarthritis treatment by efficient inflammation inhibition and extracellular matrix homeostasis restoration.基于软骨祖细胞衍生细胞外囊泡的无细胞策略通过有效抑制炎症和恢复细胞外基质稳态治疗骨关节炎。
J Nanobiotechnology. 2024 Jun 19;22(1):345. doi: 10.1186/s12951-024-02632-z.
5
Mesenchymal Stromal/stem Cell-derived Extracellular Vesicles Promote Human Cartilage Regeneration .间质基质/干细胞衍生的细胞外囊泡促进人软骨再生。
Theranostics. 2018 Jan 1;8(4):906-920. doi: 10.7150/thno.20746. eCollection 2018.
6
Counts of hyaluronic acid-containing extracellular vesicles decrease in naturally occurring equine osteoarthritis.在自然发生的马骨关节炎中,含有透明质酸的细胞外囊泡数量减少。
Sci Rep. 2022 Oct 20;12(1):17550. doi: 10.1038/s41598-022-21398-8.
7
Extracellular vesicles derived from LPS-preconditioned human synovial mesenchymal stem cells inhibit extracellular matrix degradation and prevent osteoarthritis of the knee in a mouse model.脂多糖预处理的人滑膜间充质干细胞来源的细胞外囊泡抑制细胞外基质降解并预防小鼠膝骨关节炎。
Stem Cell Res Ther. 2021 Jul 28;12(1):427. doi: 10.1186/s13287-021-02507-2.
8
Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management.间充质干细胞衍生的细胞外囊泡治疗骨关节炎:细胞外基质保护、软骨细胞和破骨细胞生理学、疼痛和炎症管理。
Cells. 2021 Oct 26;10(11):2887. doi: 10.3390/cells10112887.
9
Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis.细胞外囊泡在类风湿性关节炎和骨关节炎发病机制中的作用
Arthritis Res Ther. 2016 Dec 1;18(1):286. doi: 10.1186/s13075-016-1178-8.
10
MSC-EVs alleviate osteoarthritis by regulating microenvironmental cells in the articular cavity and maintaining cartilage matrix homeostasis.间充质干细胞外泌体通过调节关节腔中的微环境细胞和维持软骨基质稳态来缓解骨关节炎。
Ageing Res Rev. 2023 Mar;85:101864. doi: 10.1016/j.arr.2023.101864. Epub 2023 Jan 24.

引用本文的文献

1
Cathepsin K Inhibitors as Potential Drugs for the Treatment of Osteoarthritis.组织蛋白酶K抑制剂作为治疗骨关节炎的潜在药物
Int J Mol Sci. 2025 Mar 22;26(7):2896. doi: 10.3390/ijms26072896.
2
Extracellular Vesicles Derived from Human Umbilical Mesenchymal Stem Cells Transfected with miR-7704 Improved Damaged Cartilage and Reduced Matrix Metallopeptidase 13.用miR-7704转染的人脐间充质干细胞衍生的细胞外囊泡改善了受损软骨并降低了基质金属肽酶13。
Cells. 2025 Jan 9;14(2):82. doi: 10.3390/cells14020082.
3
Innovative Biotherapies and Nanotechnology in Osteoarthritis: Advancements in Inflammation Control and Cartilage Regeneration.

本文引用的文献

1
Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis-a Complex Field with Significant Potential for Future Treatments.脂肪酸和氧化脂类在骨关节炎和类风湿关节炎中的作用:一个具有巨大未来治疗潜力的复杂领域。
Curr Rheumatol Rep. 2021 Apr 28;23(6):41. doi: 10.1007/s11926-021-01007-9.
2
Characterization and Chondroprotective Effects of Extracellular Vesicles From Plasma- and Serum-Based Autologous Blood-Derived Products for Osteoarthritis Therapy.基于血浆和血清的自体血液衍生产品中细胞外囊泡用于骨关节炎治疗的表征及软骨保护作用
Front Bioeng Biotechnol. 2020 Sep 25;8:584050. doi: 10.3389/fbioe.2020.584050. eCollection 2020.
3
骨关节炎中的创新生物疗法与纳米技术:炎症控制与软骨再生的进展
Int J Mol Sci. 2024 Dec 13;25(24):13384. doi: 10.3390/ijms252413384.
4
An Update on Emerging Regenerative Medicine Applications: The Use of Extracellular Vesicles and Exosomes for the Management of Chronic Pain.新兴再生医学应用的最新进展:利用细胞外囊泡和外泌体治疗慢性疼痛
Curr Pain Headache Rep. 2024 Dec;28(12):1289-1297. doi: 10.1007/s11916-024-01309-4. Epub 2024 Nov 4.
5
Therapeutics of the future: Navigating the pitfalls of extracellular vesicles research from an osteoarthritis perspective.未来的治疗策略:从骨关节炎的角度来看待细胞外囊泡研究的陷阱。
J Extracell Vesicles. 2024 Jul;13(7):e12435. doi: 10.1002/jev2.12435.
6
Hyaluronic Acid and Large Extracellular Vesicles (EVs) in Synovial Fluid and Plasma of Patients With End-Stage Arthritis: Positive Association of EVs to Joint Pain.终末期关节炎患者滑液和血浆中的透明质酸与大型细胞外囊泡(EVs):EVs与关节疼痛的正相关关系
Cartilage. 2025 Jun;16(2):169-180. doi: 10.1177/19476035241247659. Epub 2024 May 10.
7
Role of crosstalk between synovial cells and chondrocytes in osteoarthritis (Review).滑膜细胞与软骨细胞之间的串扰在骨关节炎中的作用(综述)
Exp Ther Med. 2024 Mar 15;27(5):201. doi: 10.3892/etm.2024.12490. eCollection 2024 May.
8
Proteome and phospholipidome interrelationship of synovial fluid-derived extracellular vesicles in equine osteoarthritis: An exploratory 'multi-omics' study to identify composite biomarkers.马骨关节炎中滑液来源细胞外囊泡的蛋白质组与磷脂组相互关系:一项旨在鉴定复合生物标志物的探索性“多组学”研究
Biochem Biophys Rep. 2024 Jan 18;37:101635. doi: 10.1016/j.bbrep.2023.101635. eCollection 2024 Mar.
9
Tetraspanin profiles of serum extracellular vesicles reflect functional limitations and pain perception in knee osteoarthritis.血清细胞外囊泡的跨膜蛋白谱反映了膝骨关节炎的功能障碍和疼痛感知。
Arthritis Res Ther. 2024 Jan 22;26(1):33. doi: 10.1186/s13075-023-03234-0.
10
Extracellular vesicles in the treatment and prevention of osteoarthritis: can horses help us translate this therapy to humans?细胞外囊泡在骨关节炎治疗与预防中的应用:马匹能助我们将这种疗法应用于人类吗?
Extracell Vesicles Circ Nucl Acids. 2023 Jun;4(2):151-169. doi: 10.20517/evcna.2023.11. Epub 2023 Apr 17.
LncRNA MM2P-induced, exosome-mediated transfer of Sox9 from monocyte-derived cells modulates primary chondrocytes.
长链非编码 RNA MM2P 诱导、外泌体介导的单核细胞来源细胞 Sox9 的转移调节原代软骨细胞。
Cell Death Dis. 2020 Sep 16;11(9):763. doi: 10.1038/s41419-020-02945-5.
4
Bone marrow mesenchymal stem cell-derived exosomes protect cartilage damage and relieve knee osteoarthritis pain in a rat model of osteoarthritis.骨髓间充质干细胞来源的外泌体可保护软骨损伤,缓解骨关节炎大鼠模型中的膝骨关节炎疼痛。
Stem Cell Res Ther. 2020 Jul 10;11(1):276. doi: 10.1186/s13287-020-01781-w.
5
Exosomes: roles and therapeutic potential in osteoarthritis.外泌体:在骨关节炎中的作用及治疗潜力
Bone Res. 2020 Jun 19;8:25. doi: 10.1038/s41413-020-0100-9. eCollection 2020.
6
Role of MicroRNA, LncRNA, and Exosomes in the Progression of Osteoarthritis: A Review of Recent Literature.微小RNA、长链非编码RNA和外泌体在骨关节炎进展中的作用:近期文献综述
Orthop Surg. 2020 Jun;12(3):708-716. doi: 10.1111/os.12690. Epub 2020 May 20.
7
Intra-Articular Injections of Mesenchymal Stem Cell Exosomes and Hyaluronic Acid Improve Structural and Mechanical Properties of Repaired Cartilage in a Rabbit Model.关节内注射间充质干细胞外泌体和透明质酸可改善兔模型中修复软骨的结构和力学性能。
Arthroscopy. 2020 Aug;36(8):2215-2228.e2. doi: 10.1016/j.arthro.2020.03.031. Epub 2020 Apr 14.
8
Exosomes in clinical trial and their production in compliance with good manufacturing practice.临床试验中的外泌体及其按照药品生产质量管理规范的生产
Tzu Chi Med J. 2019 Dec 5;32(2):113-120. doi: 10.4103/tcmj.tcmj_182_19. eCollection 2020 Apr-Jun.
9
The Fibroblast-Like Synoviocyte Derived Exosomal Long Non-coding RNA H19 Alleviates Osteoarthritis Progression Through the miR-106b-5p/TIMP2 Axis.成纤维样滑膜细胞衍生的外泌体长非编码 RNA H19 通过 miR-106b-5p/TIMP2 轴缓解骨关节炎进展。
Inflammation. 2020 Aug;43(4):1498-1509. doi: 10.1007/s10753-020-01227-8.
10
Intra-articular delivery of extracellular vesicles secreted by chondrogenic progenitor cells from MRL/MpJ superhealer mice enhances articular cartilage repair in a mouse injury model.关节内注射软骨祖细胞来源的细胞外囊泡可增强 MRL/MpJ 超级愈合小鼠模型中关节软骨的修复。
Stem Cell Res Ther. 2020 Mar 2;11(1):93. doi: 10.1186/s13287-020-01594-x.